Noncanonical NF-κB activation by the oncoprotein Tio occurs through a nonconserved TRAF3-binding motif.
Sci. Signal. 6:ra27 (2013)
Members of the nuclear factor B (NF-B) family of transcription factors regulate many cellular functions. Activation of NF-B signaling is commonly classified as occurring through canonical or noncanonical pathways. Most NF-B–inducing stimuli, including the viral oncoprotein Tio, lead to a concerted activation of both NF-B pathways; however, extensive crosstalk at multiple levels between these signaling cascades restricts the ability to discriminate between the canonical and the noncanonical effects. We showed that noncanonical NF-B activation by Tio depends on a distinct sequence motif that directly recruits tumor necrosis factor receptor–associated factor 3 (TRAF3). Through its TRAF3-binding motif, Tio triggered a ubiquitin-independent depletion of TRAF3 from the cytosol, which prevented TRAF3 from inhibiting signaling through the noncanonical NF-B cascade. Furthermore, the Tio-TRAF3 interaction did not affect components of the canonical NF-B signaling pathway or the expression of target genes; thus, Tio induced noncanonical NF-B independently of crosstalk with the canonical pathway. Together, these data identify a distinct molecular mechanism of noncanonical NF-B activation that should enable studies into the particular functions of this pathway.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Epstein-barr-virus ; Human T-cells ; Herpesvirus-saimiri ; Signaling Pathway ; Protein ; Receptor ; Traf3 ; Nik ; Tnf ; Transformation
Keywords plus
Language
english
Publication Year
2013
Prepublished in Year
HGF-reported in Year
2013
ISSN (print) / ISBN
1945-0877
e-ISSN
1937-9145
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 6,
Issue: 272,
Pages: ,
Article Number: ra27
Supplement: ,
Series
Publisher
American Association for the Advancement of Science (AAAS)
Publishing Place
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Immune Response and Infection
PSP Element(s)
G-501500-005
G-508100-003
Grants
Copyright
Erfassungsdatum
2013-04-24